The University of Chicago Header Logo

Connection

Ravi Salgia to Thionucleotides

Back to Details
This is a "connection" page, showing publications Ravi Salgia has written about Thionucleotides.
Ravi Salgia
Connection Strength
0.079
Thionucleotides
  1. Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103. J Clin Oncol. 2008 Feb 20; 26(6):870-6.
    View in: PubMed
    Score: 0.079
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.